Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vsemtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
- Resource Type
- Article
- Source
- The Lancet HIV; July 2021, Vol. 8 Issue: 7 pe397-e407, 11p
- Subject
- Language
- ISSN
- 24054704; 23523018